Adverse events of immune checkpoint inhibitors in hepatocellular carcinoma: a systemic review and meta-analysis. - Tian JC; Liu H; Yan LJ; Ding ZN; Han CL; Tian BW; Tan SY; Dong ZR; Wang DX; Xue JS; Mao XC; Yan YC; et al. (Clinical and experimental medicine, 2023)